Guardian Pharmacy Recalls Magnesium Sulfate Vials Due to Sterility Concerns
Guardian Pharmacy Services is recalling 1,000 vials of Magnesium Sulfate 200 mg/mL in Texas due to a lack of sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves a lack of sterility assurance in an injectable medication, which poses a significant risk of serious injury or infection.
Plain-English summary
Guardian Pharmacy Services is recalling 1,000 vials of Magnesium Sulfate 200 mg/mL, 100 mL, prescription-only medication. The product is packaged in 100 mL MDV vials and was compounded by Guardian Pharmacy Services, located in Dallas, Texas.
The recall is being issued due to a lack of sterility assurance. The affected product is identified by Lot 58212:42 with a use-by date of 06/01/2018. The recall is limited to distribution within Texas.
Consumers and healthcare providers should stop using the affected product and contact their pharmacist or the recalling firm for further instructions.
The recalled product
- Product
- Magnesium Sulfate 200 mg/mL, 100ml. Rx. Only. Packaged in 100 mL MDV vials. Compounded Guardian Pharmacy Services, 7920 Elmbrook Dr. Ste. 108C Dallas TX 75247
- Manufacturer
- Guardian Pharmacy Services
- Category
- Drug — Injectable
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot: 58212:42 Use By: 06/01/2018
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 23 recalled by Guardian Pharmacy Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 23 products in this recall →Related recalls
Same manufacturer · Guardian Pharmacy Services
See all →- SevereGuardian Pharmacy Recalls Glutathione Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Phenol 6% Injection Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Morphine Sulfate CADD Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Cefazolin Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereGuardian Pharmacy Recalls Glycopyrrolate Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
Same hazard · sterility
See all →- SevereRegeneron Recalls Libtayo Injection Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-08-26
- SeverePrestige Recalls Clear Eyes Maximum Itchy Eye Relief Due to Sterility Concerns
FDA (Drugs) · 2026-08-19
- SevereFDA Recalls ROHTO OPTIC GLOW Eye Drops Over Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SevereROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29